Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

53.4K
Overview
53.4K
Vaccine Production01:23

Vaccine Production

30
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
30
Vaccines01:21

Vaccines

25
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
25
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbial network stability, not diversity, drives colonization resistance against Borrelia afzelii in Ixodes ricinus ticks.

Ticks and tick-borne diseases·2026
Same author

The 11<sup>th</sup> "Ticks and Tick-borne Pathogens" Conference, more than just a meeting.

Ticks and tick-borne diseases·2026
Same author

Unlocking the Black Box: The Molecular Dialogue Between ASFV and Its Tick Host.

Pathogens (Basel, Switzerland)·2026
Same author

Sublingual immunization with E2-CD154 protein and the STING agonist c-di-AMP confers protection against classical swine fever virus in pigs.

Frontiers in cellular and infection microbiology·2025
Same author

Characterization by LC-MS/MS analysis of KLH vaccine conjugated with a tick antigen peptide.

The Analyst·2025
Same author

Differential nested patterns of Anaplasma marginale and Coxiella-like endosymbiont across Rhipicephalus microplus ontogeny.

Microbiological research·2024

Related Experiment Video

Updated: Mar 22, 2026

Purification of Biotinylated Cell Surface Proteins from Rhipicephalus microplus Epithelial Gut Cells
12:03

Purification of Biotinylated Cell Surface Proteins from Rhipicephalus microplus Epithelial Gut Cells

Published on: July 23, 2017

10.0K

Developing Anti-tick Vaccines.

Alina Rodríguez-Mallon1

  • 1Animal Biotechnology Department, Center for Genetic Engineering and Biotechnology, Avenue 31 between 158 and 190, P.O. Box 6162, Havana, 10600, Cuba. alina.rodriguez@cigb.edu.cu.

Methods in Molecular Biology (Clifton, N.J.)
|April 15, 2016
PubMed
Summary
This summary is machine-generated.

Developing new anti-tick vaccines is crucial due to acaricide resistance and environmental concerns. This research explores methodologies for designing and testing novel tick protective antigens for effective vaccine development.

Keywords:
Anti-tick vaccine efficacyExperimental modelImmunizationIntegrated tick controlTickVaccine

More Related Videos

RNA Interference in Ticks
09:06

RNA Interference in Ticks

Published on: January 20, 2011

18.7K
Embryo Injection Technique for Gene Editing in the Black-Legged Tick, Ixodes scapularis
06:56

Embryo Injection Technique for Gene Editing in the Black-Legged Tick, Ixodes scapularis

Published on: September 13, 2022

3.1K

Related Experiment Videos

Last Updated: Mar 22, 2026

Purification of Biotinylated Cell Surface Proteins from Rhipicephalus microplus Epithelial Gut Cells
12:03

Purification of Biotinylated Cell Surface Proteins from Rhipicephalus microplus Epithelial Gut Cells

Published on: July 23, 2017

10.0K
RNA Interference in Ticks
09:06

RNA Interference in Ticks

Published on: January 20, 2011

18.7K
Embryo Injection Technique for Gene Editing in the Black-Legged Tick, Ixodes scapularis
06:56

Embryo Injection Technique for Gene Editing in the Black-Legged Tick, Ixodes scapularis

Published on: September 13, 2022

3.1K

Area of Science:

  • Veterinary Parasitology
  • Immunology
  • Molecular Biology

Background:

  • Ticks transmit numerous diseases to humans and animals, causing significant economic losses.
  • Acaricide use leads to resistance and environmental contamination, necessitating alternative control methods.
  • Existing vaccines like TickGARD and Gavac show limitations against diverse tick species.

Purpose of the Study:

  • To present methodologies for designing and testing novel anti-tick vaccine antigens.
  • To discuss considerations for effective anti-tick vaccine development.
  • To detail methods for establishing biological models for vaccine efficacy testing.

Main Methods:

  • Review of current tick control strategies and immunological approaches.
  • Methodologies for identifying and characterizing critical tick antigens.
  • Establishment of biological models for immunogen testing and challenge trials.
  • Efficacy calculation considerations for anti-tick vaccines.

Main Results:

  • The study outlines a framework for developing new anti-tick vaccines.
  • It highlights the importance of identifying novel antigens with critical functions in ticks.
  • Methodologies for testing immunogens and calculating vaccine efficacy are presented.

Conclusions:

  • There is a need for novel anti-tick vaccines beyond current Bm86-based formulations.
  • Research into new tick protective antigens is essential for broader tick control.
  • Standardized methodologies are required for developing and validating effective anti-tick vaccines.